JP2013500739A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013500739A5 JP2013500739A5 JP2012523432A JP2012523432A JP2013500739A5 JP 2013500739 A5 JP2013500739 A5 JP 2013500739A5 JP 2012523432 A JP2012523432 A JP 2012523432A JP 2012523432 A JP2012523432 A JP 2012523432A JP 2013500739 A5 JP2013500739 A5 JP 2013500739A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- nucleic acid
- antibody
- disease
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL200202 | 2009-08-02 | ||
| IL200202A IL200202A0 (en) | 2009-08-02 | 2009-08-02 | Novel proteins |
| PCT/IL2010/000621 WO2011016026A2 (en) | 2009-08-02 | 2010-08-02 | Novel proteins |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015047903A Division JP5833780B2 (ja) | 2009-08-02 | 2015-03-11 | 新規タンパク質 |
| JP2015155720A Division JP2015212302A (ja) | 2009-08-02 | 2015-08-06 | 新規タンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013500739A JP2013500739A (ja) | 2013-01-10 |
| JP2013500739A5 true JP2013500739A5 (https=) | 2013-09-12 |
Family
ID=42263570
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012523432A Pending JP2013500739A (ja) | 2009-08-02 | 2010-08-02 | 新規タンパク質 |
| JP2015047903A Expired - Fee Related JP5833780B2 (ja) | 2009-08-02 | 2015-03-11 | 新規タンパク質 |
| JP2015155720A Pending JP2015212302A (ja) | 2009-08-02 | 2015-08-06 | 新規タンパク質 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015047903A Expired - Fee Related JP5833780B2 (ja) | 2009-08-02 | 2015-03-11 | 新規タンパク質 |
| JP2015155720A Pending JP2015212302A (ja) | 2009-08-02 | 2015-08-06 | 新規タンパク質 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8647632B2 (https=) |
| EP (2) | EP2461829B1 (https=) |
| JP (3) | JP2013500739A (https=) |
| KR (1) | KR101623355B1 (https=) |
| CN (1) | CN102596247B (https=) |
| AU (1) | AU2010280368B2 (https=) |
| CA (1) | CA2769001C (https=) |
| IL (3) | IL200202A0 (https=) |
| IN (1) | IN2012DN00879A (https=) |
| SG (2) | SG178097A1 (https=) |
| WO (1) | WO2011016026A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140155324A1 (en) * | 2011-08-08 | 2014-06-05 | Two To Biotech Ltd. | Novel peptides and uses thereof in therapeutic methods |
| EP3089988A4 (en) * | 2014-01-02 | 2017-08-02 | Two To Biotech Ltd. | Novel polypeptides |
| CN104262468B (zh) * | 2014-09-28 | 2017-01-18 | 新乡医学院 | 一种葡萄糖转运蛋白抑制多肽及其制备方法、应用 |
| JP6560358B2 (ja) | 2015-03-05 | 2019-08-14 | セキスイ スペシャルティ ケミカルズ アメリカ リミテッド ライアビリティ カンパニー | Ｖｃｍ重合用ｐｖｏｈ分散剤 |
| AU2016367349B2 (en) * | 2015-12-11 | 2021-01-14 | National University Corporation Kochi University | Marker for pancreatic cancer and intraductal papillary mucinous neoplasms |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US5286846A (en) | 1991-06-14 | 1994-02-15 | The Government Of The United States Of America As Represented By The Dept. Of Health And Human Services | Amino acid derivative and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides |
| US6551795B1 (en) * | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
| WO2001087316A2 (en) * | 2000-05-15 | 2001-11-22 | Braswell, Glenn, A. | Composition and method for increasing testosterone levels |
| AU6992201A (en) * | 2000-06-19 | 2002-01-02 | Uab Research Foundation | Osteoclast secreted chemokine and uses thereof |
| AU2003900747A0 (en) * | 2003-02-18 | 2003-03-06 | Garvan Institute Of Medical Research | Diagnosis and treatment of pancreatic cancer |
| WO2006042002A2 (en) * | 2004-10-05 | 2006-04-20 | Oregon Health And Science University | Compositions and methods for treating disease |
| US20080248134A1 (en) * | 2005-05-04 | 2008-10-09 | Auckland Uniservices Limited | Oral compositions, use and combinations of N-[2-(dimethylamino)ethyl]-2,6 dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naphthyridine-4-carboxamide and closely related analogues thereof |
| US20090018031A1 (en) * | 2006-12-07 | 2009-01-15 | Switchgear Genomics | Transcriptional regulatory elements of biological pathways tools, and methods |
-
2009
- 2009-08-02 IL IL200202A patent/IL200202A0/en unknown
-
2010
- 2010-08-02 SG SG2012005070A patent/SG178097A1/en unknown
- 2010-08-02 WO PCT/IL2010/000621 patent/WO2011016026A2/en not_active Ceased
- 2010-08-02 KR KR1020127004449A patent/KR101623355B1/ko not_active Expired - Fee Related
- 2010-08-02 IN IN879DEN2012 patent/IN2012DN00879A/en unknown
- 2010-08-02 JP JP2012523432A patent/JP2013500739A/ja active Pending
- 2010-08-02 US US13/387,392 patent/US8647632B2/en active Active
- 2010-08-02 CA CA2769001A patent/CA2769001C/en not_active Expired - Fee Related
- 2010-08-02 EP EP10806144.1A patent/EP2461829B1/en not_active Not-in-force
- 2010-08-02 AU AU2010280368A patent/AU2010280368B2/en not_active Ceased
- 2010-08-02 SG SG10201404735VA patent/SG10201404735VA/en unknown
- 2010-08-02 EP EP15182357.2A patent/EP2985035A1/en not_active Withdrawn
- 2010-08-02 CN CN201080044688.3A patent/CN102596247B/zh not_active Expired - Fee Related
-
2012
- 2012-01-26 IL IL217758A patent/IL217758A/en not_active IP Right Cessation
-
2015
- 2015-03-11 JP JP2015047903A patent/JP5833780B2/ja not_active Expired - Fee Related
- 2015-07-23 IL IL240134A patent/IL240134A/en not_active IP Right Cessation
- 2015-08-06 JP JP2015155720A patent/JP2015212302A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis | |
| AU2014317035B2 (en) | IL-18 binding protein (IL-18BP) in inflammatory diseases | |
| US12173055B2 (en) | N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto | |
| Cavone et al. | Increase in the level of proinflammatory cytokine HMGB1 in nasal fluids of patients with rhinitis and its sequestration by glycyrrhizin induces eosinophil cell death | |
| CN106164675B (zh) | 检测人类骨膜蛋白的新型测定 | |
| EP3076985B1 (en) | Composition comprising probiotics overexpressing clpb protein for use in the treatment of obesity | |
| JP2013500739A5 (https=) | ||
| WO2016141334A2 (en) | Compositions and methods for diagnosing and treating autoimmune diseases | |
| AU2024284360A9 (en) | Tnf inhibitor combination therapies | |
| EP2838559B1 (en) | Combination therapy of anti-mif antibodies and glucocorticoids | |
| WO2014165866A2 (en) | Methods for immune-based diagnosis, prevention and personalized treatment of narcolepsy | |
| WO2011038689A1 (zh) | 人类新细胞因子VSTM1-v2及其应用 | |
| AU2020323925A1 (en) | Antibodies to Candida and uses thereof | |
| CN102307894B (zh) | 螨过敏原之变体及其用途 | |
| CN119390843B (zh) | 抗tl1a抗体及其制备方法和应用 | |
| WO2022196816A1 (ja) | 急性肺障害および肺線維症の急性増悪を改善するための医薬組成物 | |
| Matsuno et al. | Increased serum ADAM8 concentration in patients with drug-induced eosinophilic pneumonia-ADAM8 expression depends on a the allergen route of entry | |
| CN106810603B (zh) | 一种多肽及其应用 | |
| KR20170098941A (ko) | 인간 dpp-4를 검출하기 위한 검정법 | |
| WO2014181273A1 (en) | Methods for treating inflammatory bowel disease | |
| US20260116957A1 (en) | Pharmaceutical composition for ameliorating acute lung injury and acute worsening of pulmonary fibrosis | |
| CN117425672A (zh) | 用于改善急性肺损伤和肺纤维化急性加重的药物组合物 | |
| US20230416381A1 (en) | Methods for treating or preventing acute respiratory distress syndrome | |
| EP4573121A1 (en) | Method of selecting patients for treatment with an il-33 axis antagonist | |
| Qi et al. | The involvement of proline-rich protein Mus musculus predicted gene 4736 in ocular surface functions |